| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10918597 | Radiotherapy and Oncology | 2014 | 6 Pages |
Abstract
The addition of Cetuximab to radiotherapy and concurrent Cisplatin did not improve disease control in patients with locally advanced NSCLC but increased treatment related toxicity.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Michel M. van den Heuvel, Wilma Uyterlinde, Andrew D. Vincent, Jeroen de Jong, Joachim Aerts, Frederike Koppe, Joost Knegjens, Henk Codrington, Peter W.E. Kunst, Edith Dieleman, Marcel Verheij, José Belderbos,